Xiaoxiao Wang

Beijing Key Laboratory Of Hepatitis C And Immunotherapy For Liver Diseases
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease.

Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease.

Journal: Diagnostics (Basel, Switzerland)

Published: December 08, 2025

Development of a CT radiomics and clinical feature combined model for predicting early recurrence of surgical resected hepatocellular carcinoma.

Development of a CT radiomics and clinical feature combined model for predicting early recurrence of surgical resected hepatocellular carcinoma.

Journal: Scientific reports

Published: July 10, 2025

Proteome Profiling of Experimental Autoimmune Encephalomyelitis Mouse Model and the Effect of a SUMO E1 Inhibitor.

Proteome Profiling of Experimental Autoimmune Encephalomyelitis Mouse Model and the Effect of a SUMO E1 Inhibitor.

Journal: Journal of proteome research

Published: November 21, 2024

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.

Journal: BMC gastroenterology

Published: September 29, 2024

Tracking the Helicobacter pylori Epidemic in Adults and Children in China.

Tracking the Helicobacter pylori Epidemic in Adults and Children in China.

Journal: Helicobacter

Published: July 18, 2024

Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.

Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.

Journal: Current medicinal chemistry

Published: October 23, 2023

Mortality Burden of Liver Cancer in China: An Observational Study From 2008 to 2020.

Mortality Burden of Liver Cancer in China: An Observational Study From 2008 to 2020.

Journal: Journal of clinical and translational hepatology

Published: October 10, 2023

Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020.

Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020.

Journal: Journal of clinical and translational hepatology

Published: October 10, 2023

eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population - China, 2010-2023.

eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population - China, 2010-2023.

Journal: China CDC weekly

Published: September 01, 2023

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α.

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α.

Journal: Nature communications

Published: June 21, 2023

Trends of Mortality in End-Stage Liver Disease - China, 2008-2020.

Trends of Mortality in End-Stage Liver Disease - China, 2008-2020.

Journal: China CDC weekly

Published: May 16, 2023

LAMP3 expression in the liver is involved in T cell activation and adaptive immune regulation in hepatitis B virus infection.

LAMP3 expression in the liver is involved in T cell activation and adaptive immune regulation in hepatitis B virus infection.

Journal: Frontiers in immunology

Published: December 19, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026